ArticleFrontiers in medicine2026
Luteal-phase stimulation does not compromise embryo euploidy or live birth outcomes compared to follicular-phase stimulation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aneuploidy is a major cause of implantation failure and miscarriage in assisted reproductive technology. This study aimed to evaluate embryo euploidy and live birth rates associated with the luteal-phase stimulation (LPS) protocol in Methods: We conducted a retrospective cohort study at a university-affiliated fertility center, including 667 preimplantation genetic testing for aneuploidy (PGT-A) cycles performed between January 2020 and June 2023. After 1:1 propensity score matching, 106 cycles were analyzed from each group (LPS and FPS). Baseline characteristics, ovarian stimulation parameters, euploidy rate, and subsequent reproductive outcomes were compared. Results: After matching, baseline characteristics were comparable between the groups. The LPS group required a longer duration of gonadotropin stimulation (median 10.5 vs. 9 days, Conclusion: The LPS protocol demonstrated similar embryo euploidy and live birth rates to the FPS protocol, suggesting that LPS does not compromise chromosomal competence or reproductive outcomes. However, the lower oocyte yield in the LPS group could potentially affect cumulative pregnancy and live birth rates. Given its scheduling flexibility, LPS may still represent a clinically feasible and patient-friendly option in assisted reproductive technology (ART).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.